{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:48:48Z","timestamp":1787240928906,"version":"build-2736575974"},"reference-count":65,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1248\/bpb.b16-00438","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T18:12:27Z","timestamp":1475259147000},"page":"1569-1575","source":"Crossref","is-referenced-by-count":13,"title":["New Age Therapy for Alzheimer\u2019s Disease by Neuronal Network Reconstruction"],"prefix":"10.1248","volume":"39","author":[{"given":"Chihiro","family":"Tohda","sequence":"first","affiliation":[{"name":"Division of Neuromedical Science, Department of Bioscience, Institute of Natural Medicine, University of Toyama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Tan CC, Yu JT, Wang HF, Tan MS, Meng XF, Wang C, Jiang T, Zhu XC, Tan L. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis. <i>J. Alzheimer\u2019s Dis.<\/i>, <b>41<\/b>, 615\u2013631 (2014)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Tricco AC, Soobiah C, Berliner S, Ho JM, Ng CH, Ashoor HM, Chen MH, Hemmelgarn B, Straus SE. Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis. <i>Can. Med. Assoc. J.<\/i>, <b>185<\/b>, 1393\u20131401 (2013).","DOI":"10.1503\/cmaj.130451"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, Sabbagh M, Honig LS, Doody R, van Dyck CH, Mulnard R, Barakos J, Gregg KM, Liu E, Lieberburg I, Schenk D, Black R, Grundman M. Bapineuzumab 201 Clinical Trial Investigators. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer\u2019s disease. <i>Neurology<\/i>, <b>73<\/b>, 2061\u20132070 (2009).","DOI":"10.1212\/WNL.0b013e3181c67808"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Henley DB, May PC, Dean RA, Siemers ER. Siemers, E. R. Development of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer\u2019s disease. <i>Expert Opin. Pharmacother.<\/i>, <b>10<\/b>, 1657\u20131664 (2009).","DOI":"10.1517\/14656560903044982"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Dickson TC, Vickers JC. The morphological phenotype of \u03b2-amyloid plaques and associated neuritic changes in Alzheimer\u2019s disease. <i>Neuroscience<\/i>, <b>105<\/b>, 99\u2013107 (2001).","DOI":"10.1016\/S0306-4522(01)00169-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. <i>Ann. Neurol.<\/i>, <b>30<\/b>, 572\u2013580 (1991).","DOI":"10.1002\/ana.410300410"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tohda C, Kuboyama T, Komatsu K. Search for natural products related to regeneration of the neuronal network. <i>Neurosignals<\/i>, <b>14<\/b>, 34\u201345 (2005).","DOI":"10.1159\/000085384"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN, Li WY. Secondary structure of amyloid \u03b2 peptide correlates with neurotoxic activity <i>in vitro.<\/i> <i>Mol. Pharmacol.<\/i>, <b>45<\/b>, 373\u2013379 (1994).","DOI":"10.1016\/S0026-895X(25)10007-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Bobinski M, Wegiel J, Tarnawski M, Bobinski M, Reisberg B, de Leon MJ, Miller DC, Wisniewski HM. Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer\u2019s disease. <i>J. Neuropathol. Exp. Neurol.<\/i>, <b>56<\/b>, 414\u2013420 (1997).","DOI":"10.1097\/00005072-199704000-00010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Canning DR, McKeon RJ, DeWitt DA, Perry G, Wujek JR, Frederickson RC, Silver J. Amyloid of Alzheimer\u2019s disease induces reactive gliosis that inhibits axonal outgrowth. <i>Exp. Neurol.<\/i>, <b>124<\/b>, 289\u2013298 (1993).","DOI":"10.1006\/exnr.1993.1199"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Knowles RB, Wyart C, Buldyrev SV, Cruz L, Urbanc B, Hasselmo ME, Stanley HE, Hyman BT. Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer\u2019s disease. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>96<\/b>, 5274\u20135279 (1999).","DOI":"10.1073\/pnas.96.9.5274"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW. Structure activity analyses of \u03b2-amyloid peptides: contribution of the \u03b225\u201335 region to aggregation and neurotoxicity. <i>J. Neurochem.<\/i>, <b>64<\/b>, 253\u2013265 (1995).","DOI":"10.1046\/j.1471-4159.1995.64010253.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid \u03b2 protein: reversal by tachykinin neuropeptides. <i>Science<\/i>, <b>250<\/b>, 279\u2013282 (1990).","DOI":"10.1126\/science.2218531"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Grace EA, Rabiner CA, Busciglio J. Characterization of neuronal dystrophy induced by fibrillar amyloid \u03b2: implications for Alzheimer\u2019s disease. <i>Neuroscience<\/i>, <b>114<\/b>, 265\u2013273 (2002).","DOI":"10.1016\/S0306-4522(02)00241-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sun MK, Alkon DL. Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by \u03b2-amyloid(25\u201335). <i>J. Neurophysiol.<\/i>, <b>87<\/b>, 2441\u20132449 (2002).","DOI":"10.1152\/jn.00230.2001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tohda C, Tamura T, Komatsu K. Repair of amyloid \u03b2(25\u201335)-induced memory impairment and synaptic loss by a Kampo formula, Zokumei-to. <i>Brain Res.<\/i>, <b>990<\/b>, 141\u2013147 (2003).","DOI":"10.1016\/S0006-8993(03)03449-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Maurice T, Lockhart BP, Privat A. Amnesia induced in mice by centrally administered \u03b2-amiloid peptides involves cholinergic dysfunction. <i>Brain Res.<\/i>, <b>706<\/b>, 181\u2013193 (1996).","DOI":"10.1016\/0006-8993(95)01032-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kuboyama T, Tohda C, Komatsu K. Neuritic regeneration and synaptic reconstruction induced by withanolide A. <i>Br. J. Pharmacol.<\/i>, <b>144<\/b>, 961\u2013971 (2005).","DOI":"10.1038\/sj.bjp.0706122"},{"key":"19","unstructured":"19) Sivarajan VV, Balachandran I. <i>Ayurvedic drugs and their plant sources<\/i>. International Science Publisher, New York (1994)."},{"key":"20","unstructured":"20) Warrier PK, Nambiar VPK, Ramankutty C. <i>Indian Medicinal Plants: A Compendium of 500 Species.<\/i> Orient Longman, Madras, India (1996)."},{"key":"21","unstructured":"21) Usmanghani K, Saeed A, Alam MT. <i>Indusyunic medicine: traditional medicine of herbal, animal, and mineral origin in Pakistan.<\/i> Dept. of Pharmacognosy, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan (1997)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kulkarni SK, Dhir A. <i>Withania somnifera<\/i>: an Indian ginseng. <i>Prog. Neuropsychopharmacol. Biol. Psychiatry<\/i>, <b>32<\/b>, 1093\u20131105 (2008).","DOI":"10.1016\/j.pnpbp.2007.09.011"},{"key":"23","unstructured":"23) Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of <i>Withania somnifera<\/i> (Ashwagandha): a review. <i>Altern. Med. Rev.<\/i>, <b>5<\/b>, 334\u2013346 (2000)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Zhao J, Nakamura N, Hattori M, Kuboyama T, Tohda C, Komatsu K. Withanolide derivatives from the roots of <i>Withania somnifera<\/i> and their neurite outgrowth activities. <i>Chem. Pharm. Bull.<\/i>, <b>50<\/b>, 760\u2013765 (2002).","DOI":"10.1248\/cpb.50.760"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kuboyama T, Tohda C, Zhao J, Nakamura N, Hattori M, Komatsu K. Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. <i>Neuroreport<\/i>, <b>13<\/b>, 1715\u20131720 (2002).","DOI":"10.1097\/00001756-200210070-00005"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kuboyama T, Tohda C, Komatsu K. Withanoside IV and its active metabolite, sominone, attenuate A\u03b2(25\u201335)-induced neurodegeneration. <i>Eur. J. Neurosci.<\/i>, <b>23<\/b>, 1417\u20131426 (2006).","DOI":"10.1111\/j.1460-9568.2006.04664.x"},{"key":"27","unstructured":"27) Tohda C, Komatsu K, Kuboyama T. Scientific basis for the anti-dementia drugs of constituents from Ashwagandha (<i>Withania somnifera<\/i>). <i>J. Trad. Med.<\/i>, <b>22<\/b>, 176\u2013182 (2005)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Tohda C, Joyashiki E. Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET. <i>Br. J. Pharmacol.<\/i>, <b>157<\/b>, 1427\u20131440 (2009).","DOI":"10.1111\/j.1476-5381.2009.00313.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Zhao R, McDaniel WF. Ginseng improves strategiclearning by normal and brain-damaged rats. <i>Neuroreport<\/i>, <b>9<\/b>, 1619\u20131624 (1998).","DOI":"10.1097\/00001756-199805110-00066"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Wang LC, Wang B, Ng SY, Lee TF. Effects of ginseng saponins on beta-amyloid-induced amnesia in rats. <i>J. Ethnopharmacol.<\/i>, <b>103<\/b>, 103\u2013108 (2006).","DOI":"10.1016\/j.jep.2005.07.010"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Zhong YM, Nishijo H, Uwano T, Tamura R, Kawanishi K, Ono T. Red ginseng ameliorated place navigation deficits in young rats with hippocampal lesions and aged rats. <i>Physiol. Behav.<\/i>, <b>69<\/b>, 511\u2013525 (2000).","DOI":"10.1016\/S0031-9384(00)00206-7"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Mook-Jung I, Hong HS, Boo JH, Lee KH, Yun SH, Cheong MY, Joo I, Huh K, Jung MW. Ginsenoside Rb1 and Rg1 improve spatial learning and increase hippocampal synaptophysin level in mice. <i>J. Neurosci. Res.<\/i>, <b>63<\/b>, 509\u2013515 (2001).","DOI":"10.1002\/jnr.1045"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Tohda C, Matsumoto N, Zou K, Meselhy RM, Komatsu K. Axonal and dendritic extension by protopanaxadiol-type saponins from Ginseng drugs in SK-N-SH cells. <i>Jpn. J. Pharmacol.<\/i>, <b>90<\/b>, 254\u2013262 (2002).","DOI":"10.1254\/jjp.90.254"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Tohda C, Matsumoto N, Zou K, Meselhy MR, Komatsu KA. \u03b2(25\u201335)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins. <i>Neuropsychopharmacology<\/i>, <b>29<\/b>, 860\u2013868 (2004).","DOI":"10.1038\/sj.npp.1300388"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Tohda C, Tamura T, Matsuyama S, Komatsu K. Promotion of axonal maturation and prevention of memory loss in mice by extracts of <i>Astragalus mongholicus<\/i>. <i>Br. J. Pharmacol.<\/i>, <b>149<\/b>, 532\u2013541 (2006).","DOI":"10.1038\/sj.bjp.0706865"},{"key":"36","unstructured":"36) Yan LL, Zhang YJ, Gao WY, Man SL, Wang Y. <i>In vitro<\/i> and <i>in vivo<\/i> anticancer activity of steroid saponins of <i>Paris polyphylla<\/i> var. <i>yunnanensis.<\/i> <i>Exp. Oncol.<\/i>, <b>31<\/b>, 27\u201332 (2009)."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Huang CH, Ku AY, Jan TR. Diosgenin attenuates allergen-induced intestinal inflammation and IgE production in a murine model of food allergy. <i>Planta Med.<\/i>, <b>75<\/b>, 1300\u20131305 (2009).","DOI":"10.1055\/s-0029-1185578"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Chiu CS, Chiu YJ, Wu LY, Lu TC, Huang TH, Hsieh MT, Lu CY, Peng WH. Diosgenin ameliorates cognition deficit and attenuates oxidative damage in senescent mice induced by D-galactose. <i>Am. J. Chin. Med.<\/i>, <b>39<\/b>, 551\u2013563 (2011).","DOI":"10.1142\/S0192415X11009020"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Kang TH, Moon E, Hong BN, Choi SZ, Son M, Park JH, Kim SY. Diosgenin from <i>Dioscorea nipponica<\/i> ameliorates diabetic neuropathy by inducing nerve growth factor. <i>Biol. Pharm. Bull.<\/i>, <b>34<\/b>, 1493\u20131498 (2011).","DOI":"10.1248\/bpb.34.1493"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Lecanu L, Rammouz G, McCourty A, Sidahmed EK, Greeson J, Papadopoulos V. Caprospinol reduces amyloid deposits and improves cognitive function in a rat model of Alzheimer\u2019s disease. <i>Neuroscience<\/i>, <b>165<\/b>, 427\u2013435 (2010).","DOI":"10.1016\/j.neuroscience.2009.10.033"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. <i>J. Neurosci.<\/i>, <b>26<\/b>, 10129\u201310140 (2006).","DOI":"10.1523\/JNEUROSCI.1202-06.2006"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Eriksen JL, Janus CG. Plaques, tangles, and memory loss in mouse models of neurodegeneration. <i>Behav. Genet.<\/i>, <b>37<\/b>, 79\u2013100 (2007).","DOI":"10.1007\/s10519-006-9118-z"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Ohno M. Failures to reconsolidate memory in a mouse model of Alzheimer\u2019s disease. <i>Neurobiol. Learn. Mem.<\/i>, <b>92<\/b>, 455\u2013459 (2009).","DOI":"10.1016\/j.nlm.2009.05.001"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Urano T, Tohda C. Icariin improves memory impairment in Alzheimer\u2019s disease model mice (5xFAD) and attenuates amyloid \u03b2-induced neurite atrophy. <i>Phytother. Res.<\/i>, <b>24<\/b>, 1658\u20131663 (2010).","DOI":"10.1002\/ptr.3183"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Joyashiki E, Matsuya Y, Tohda C. Sominone improves memory ipairments and increases axonal density in Alzheimer\u2019s disease model mice, 5XFAD. <i>Int. J. Neurosci.<\/i>, <b>121<\/b>, 181\u2013190 (2011).","DOI":"10.3109\/00207454.2010.541571"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Tohda C, Nakada R, Urano T, Okonogi A, Kuboyama T. Kamikihi-to (KKT) rescues axonal and synaptic degeneration associated with memory impairment in a mouse model of Alzheimer\u2019s disease, 5XFAD. <i>Int. J. Neurosci.<\/i>, <b>121<\/b>, 641\u2013648 (2011).","DOI":"10.3109\/00207454.2011.602809"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Zhang XM, Cai Y, Xiong K, Cai H, Luo XG, Feng JC, Clough RW, Struble RG, Patrylo PR, Yan XX. \u03b2-Secretase-1 elevation in transgenic mouse models of Alzheimer\u2019s disease is associated with synaptic\/axonal pathology and amyloidogenesis: implications for neuritic plaque development. <i>Eur. J. Neurosci.<\/i>, <b>30<\/b>, 2271\u20132283 (2009).","DOI":"10.1111\/j.1460-9568.2009.07017.x"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Trujillo-Estrada L, D\u00e1vila JC, S\u00e1nchez-Mejias E, S\u00e1nchez-Varo R, Gomez-Arboledas A, Vizuete M, Vitorica J, Guti\u00e9rrez A. Early neuronal loss and axonal\/presynaptic damage is associated with accelerated amyloid-\u03b2 accumulation in A\u00dfPP\/PS1 Alzheimer\u2019s disease mice subiculum. <i>J. Alzheimer\u2019s Dis.<\/i>, <b>42<\/b>, 521\u2013541 (2014).","DOI":"10.3233\/JAD-140495"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Dickson TC, King CE, McCormack GH, Vickers JC. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer\u2019s disease. <i>Exp. Neurol.<\/i>, <b>156<\/b>, 100\u2013110 (1999).","DOI":"10.1006\/exnr.1998.7010"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Tohda C, Urano T, Umezaki M, Nemere I, Kuboyama T. Diosgenin is an exogenous activator of 1,25D<sub>3<\/sub>-MARRS\/Pdia3\/ERp57 and improves Alzheimer\u2019s disease pathologies in 5XFAD mice. <i>Sci. Rep<\/i>, <b>2<\/b>, 535 (2012).","DOI":"10.1038\/srep00535"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Lomenick B, Hao R, Jonai N, Chin RM, Aghajan M, Warburton S, Wang J, Wu RP, Gomez F, Loo JA, Wohlschlegel JA, Vondriska TM, Pelletier J, Herschman HR, Clardy J, Clarke CF, Huang J. Target identification using drug affinity responsive target stability (DARTS). <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>106<\/b>, 21984\u201321989 (2009).","DOI":"10.1073\/pnas.0910040106"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Wu W, Beilhartz G, Roy Y, Richard CL, Curtin M, Brown L, Cadieux D, Coppolino M, Farach-Carson MC, Nemere I, Meckling KA. Nuclear translocation of the 1,25D<sub>3<\/sub>-MARRS (membrane associated rapid response to steroids) receptor protein and NF-\u03baB in differentiating NB4 leukemia cells. <i>Exp. Cell Res.<\/i>, <b>316<\/b>, 1101\u20131108 (2010).","DOI":"10.1016\/j.yexcr.2010.01.010"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Guo GG, Patel K, Kumar V, Shah M, Fried VA, Etlinger JD, Sehgal PB. Association of the chaperone glucose-regulated protein 58 (GRP58\/ER-60\/ERp57) with Stat3 in cytosol and plasma membrane complexes. <i>J. Interferon Cytokine Res.<\/i>, <b>22<\/b>, 555\u2013563 (2002).","DOI":"10.1089\/10799900252982034"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Larsson B, Nemere I. Effect of growth and maturation on membrane-initiated actions of 1,25-dihydroxyvitamin D3-II: calcium transport, receptor kinetics, and signal transduction in intestine of female chickens. <i>J. Cell. Biochem.<\/i>, <b>90<\/b>, 901\u2013913 (2003).","DOI":"10.1002\/jcb.10696"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Nemere I, Farach-Carson MC, Rohe B, Sterling TM, Norman AW, Boyan BD, Safford SE. Ribozyme knockdown functionally links a 1,25(OH)<sub>2<\/sub>D<sub>3<\/sub> membrane binding protein (1,25D<sub>3<\/sub>-MARRS) and phosphate uptake in intestinal cells. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>101<\/b>, 7392\u20137397 (2004).","DOI":"10.1073\/pnas.0402207101"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Rosso A, Pansera M, Zamoner A, Zanatta L, Boura\u00efma-Lelong H, Carreau S, Silva FR. 1\u03b1,25(OH)<sub>2<\/sub>-Vitamin D3 stimulates rapid plasma membrane calcium influx <i>via<\/i> MAPK activation in immature rat <i>Sertoli<\/i> cells. <i>Biochimie<\/i>, <b>94<\/b>, 146\u2013154 (2012).","DOI":"10.1016\/j.biochi.2011.10.001"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Buitrago C, Arango N, Boland R. 1\u03b1,25(OH)<sub>2<\/sub>D<sub>3<\/sub>-dependent modulation of Akt in proliferating and differentiating C2C12 skeletal muscle cells. <i>J. Cell. Biochem.<\/i>, <b>113<\/b>, 1170\u20131181 (2012).","DOI":"10.1002\/jcb.23444"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Tohda C, Lee YA, Goto Y, Nemere I. Diosgenin-induced cognitive enhancement in normal mice is mediated by 1,25D<sub>3<\/sub>-MARRS. <i>Sci. Rep<\/i>, <b>3<\/b>, 3395 (2013).","DOI":"10.1038\/srep03395"},{"key":"59","unstructured":"59) Magome A. Effect of kamikihito on dementia. <i>Kampo Newest Ther.<\/i>, <b>23<\/b>, 135\u2013140 (2014)."},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Watari H, Shimada Y, Tohda C. New treatment for Alzheimer\u2019s disease, kamikihito, reverses amyloid-\u03b2-induced progression of tau phosphorylation and axonal atrophy. <i>Evid. Based Complement. Alternat. Med.<\/i>, <b>2014<\/b>, 706487 (2014).","DOI":"10.1155\/2014\/706487"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Watari H, Shimada Y, Tohda C. Cytosolic aspartate aminotransferase, a direct binding protein of kamikihito, regulates axon growth. <i>Traditional Kampo Medicine<\/i>, <b>3<\/b>, 41\u201349 (2016).","DOI":"10.1002\/tkm2.1037"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) McKenna MC, Waagepetersen HS, Schousboe A, Sonnewald U. Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools. <i>Biochem. Pharmacol.<\/i>, <b>71<\/b>, 399\u2013407 (2006).","DOI":"10.1016\/j.bcp.2005.10.011"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Yang ZY, Kuboyama T, Kazuma K, Konno K, Tohda C. Active constituents from <i>Drynaria fortunei<\/i> Rhizomes on the attenuation of A\u03b2(25\u201335)-induced axonal atrophy. <i>J. Nat. Prod.<\/i>, <b>78<\/b>, 2297\u20132300 (2015).","DOI":"10.1021\/acs.jnatprod.5b00290"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Tohda C, Ichimura M, Bai Y, Tanaka K, Zhu S, Komatsu K. Inhibitory effects of <i>Eleutherococcus senticosus<\/i> extracts on amyloid \u03b2(25\u201335)-induced neuritic atrophy and synaptic loss. <i>J. Pharmacol. Sci.<\/i>, <b>107<\/b>, 329\u2013339 (2008).","DOI":"10.1254\/jphs.08046FP"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Bai Y, Tohda C, Zhu S, Hattori M, Komatsu K. Active components from Siberian ginseng (<i>Eleutherococcus senticosus<\/i>) for protection of amyloid \u03b2(25\u201335)-induced neuritic atrophy in cultured rat cortical neurons. <i>J. Nat. Med.<\/i>, <b>65<\/b>, 417\u2013423 (2011).","DOI":"10.1007\/s11418-011-0509-y"}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/10\/39_b16-00438\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:12:05Z","timestamp":1749579125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/10\/39_b16-00438\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00438","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}